U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07416734) titled 'RCT of HeartBot in Women' on Feb. 11.
Brief Summary: The goal of this clinical trial is to find out whether an app-based program called HeartBot II, which uses an artificial intelligence (AI) chatbot, can help improve women's awareness and knowledge of heart attacks in women.
This is an online study with about 200 women taking part. Participants will be randomly assigned (by chance) to one of two groups: an intervention group or a wait-list control group.
Participants in the intervention group will begin using the HeartBot II program right away. Participants in the wait-list control group will wait 12 weeks before starting the Hea...